We currently don't have sufficient analyst coverage to forecast growth and revenue for Biotest.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth
23.4%
Revenue growth rate
n/a
Future return on equity
n/a
Analyst coverage
None
Last updated
n/a
Recent future growth updates
Recent updates
In this section we usually present revenue and earnings growth
projections based on the consensus estimates of professional
analysts to help investors understand the company’s ability to
generate profit. But as Biotest has not provided enough
past data and has no analyst forecast, its future earnings
cannot be reliably calculated by extrapolating past data or
using analyst predictions.
This is quite a rare situation as 97% of companies covered by
SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
OTCPK:BTTA.Y - Analysts future estimates and past financials data (EUR Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2025
635
-24
-14
14
N/A
12/31/2024
726
26
32
61
N/A
9/30/2024
707
69
56
90
N/A
6/30/2024
781
164
86
119
N/A
3/31/2024
783
177
-10
23
N/A
12/31/2023
685
127
-36
-3
N/A
9/30/2023
656
91
-122
-93
N/A
6/30/2023
538
-10
-146
-117
N/A
3/31/2023
517
-47
-127
-98
N/A
12/31/2022
516
-32
-70
-40
N/A
9/30/2022
505
-69
-4
14
N/A
6/30/2022
511
-65
30
49
N/A
3/31/2022
512
-54
51
69
N/A
12/31/2021
516
-63
16
34
N/A
9/30/2021
514
-28
-3
24
N/A
6/30/2021
507
-33
-32
-5
N/A
3/31/2021
507
-35
-49
-22
N/A
12/31/2020
484
-31
-44
-17
N/A
9/30/2020
466
-34
-74
-40
N/A
6/30/2020
459
-24
-83
-49
N/A
3/31/2020
439
-15
-70
-36
N/A
12/31/2019
419
-5
-68
-34
N/A
9/30/2019
406
-9
-74
-19
N/A
6/30/2019
395
-3
-61
-6
N/A
3/31/2019
390
-6
-81
-26
N/A
12/31/2018
400
-13
N/A
-50
N/A
9/30/2018
405
18
N/A
-16
N/A
6/30/2018
409
6
N/A
6
N/A
3/31/2018
400
1
N/A
15
N/A
12/31/2017
378
-16
N/A
34
N/A
9/30/2017
257
-48
N/A
8
N/A
6/30/2017
301
-47
N/A
-8
N/A
3/31/2017
340
-29
N/A
35
N/A
12/31/2016
408
6
N/A
66
N/A
9/30/2016
531
128
N/A
51
N/A
6/30/2016
525
52
N/A
57
N/A
3/31/2016
526
36
N/A
44
N/A
12/31/2015
535
27
N/A
38
N/A
9/30/2015
590
-88
N/A
62
N/A
6/30/2015
606
3
N/A
54
N/A
3/31/2015
602
16
N/A
15
N/A
12/31/2014
582
19
N/A
-11
N/A
9/30/2014
543
27
N/A
-26
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BTTA.Y's forecast earnings growth is above the savings rate (2.9%).
Earnings vs Market: Insufficient data to determine if BTTA.Y's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if BTTA.Y's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BTTA.Y's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if BTTA.Y's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BTTA.Y's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2025/07/01 09:42
End of Day Share Price
2025/04/03 00:00
Earnings
2025/03/31
Annual Earnings
2024/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biotest Aktiengesellschaft is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.